Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Associations of <sup>18</sup>F-RO-948 tau PET with fluid AD biomarkers, Centiloid, and cognition in early AD continuum.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Performance of a fully automated plasma tau phosphorylated at threonine 217 immunoassay to reflect amyloid-beta burden in an unselected cohort representative of clinical practice.

The journal of prevention of Alzheimer's disease·2026
Same author

Physical activity across the life course and neural biomarkers.

Journal of Alzheimer's disease : JAD·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

High-Density EEG Source Localisation of averaged interictal epileptic Discharges validated by surgical Outcome.

Scientific data·2025

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Imke Kirste1, David Caley2, Clara Quijano Rubio3

  • 1Roche Diagnostics, Durham, NC, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括

临床试验设计可以更好地代表各种患者群体,包括少数群体和伴随疾病患者. 这种方法导致更准确的诊断测试结果和更好的阿尔茨海默病的推出后实用性.

科学领域:

  • 生物标志物开发 生物标志物开发
  • 临床试验设计 临床试验设计
  • 神经退行性疾病 神经退行性疾病

背景情况:

  • 获得医疗保健和诊断测试的可用性在人口中分布不均.
  • 目前的诊断测试开发往往缺乏少数群体和伴随疾病的个体的代表性.
  • 改善临床试验设计对于开发有利于更广泛患者群体的医学试验至关重要.

研究的目的:

  • 开发一种新的基于血液的生物标志物,用于早期阿尔茨海默病的进展.
  • 确保在临床研究中招募多样化的患者,包括种族/族裔少数群体和患有并发病的人.
  • 创建具有更广泛的临床价值和现实世界的应用性诊断测试.

主要方法:

  • 实施患者招募的移动单位,并利用多语言的学习材料.
  • 根据地理位置和多样化的招生能力,进行外展活动和选择学习地点.
  • 在临床试验中招募1500名患者,该试验有两个部分:切断界限的确定和验证.

主要成果:

  • 该研究实现了种族和民族少数群体的显著代表性,并包括多种并发病症的患者.
  • 在切断确定臂 (n=600) 中,有64.5%的非西班牙裔白人,12.5%的非洲裔美国人和其他少数民族被纳入.
  • 患者群体反映了各种共同疾病,包括心血管,代谢,神经和瘤疾病.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

结论:

  • 一个精心设计的临床试验可以准确地反映现实世界患者群体.
  • 这种改进的表现导致更准确的诊断测试结果.
  • 改进的试验设计确保更好地反映了发射后的使用和临床效用.